Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP- for Patients with Substance Use Disorder (SUD)
Shots:
- The launch is in based on the results of study evaluating reSET vs outpatient therapy alone showing improved recovery & abstinence from patients’ substances of abuse with increased retention time
- reSET is a 12 week (90-day) FDA approved- digital cognitive behavioral therapy with medical mobile app for patients aged ≥- used in combination with outpatient clinician-delivered care- offering complete module treatments with face to face therapy sessions
- Companies have also launched support center- reSET Connect Patient Service Center supporting patients to assess reSET app. In April- 2018 Sandoz collaborated with Pear to develop & commercialize reSET for patients with SUD
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
